CRNX
Price
$32.32
Change
+$0.19 (+0.59%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
3.03B
63 days until earnings call
IMTX
Price
$5.81
Change
+$0.06 (+1.04%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
706.21M
68 days until earnings call
Interact to see
Advertisement

CRNX vs IMTX

Header iconCRNX vs IMTX Comparison
Open Charts CRNX vs IMTXBanner chart's image
Crinetics Pharmaceuticals
Price$32.32
Change+$0.19 (+0.59%)
Volume$7.99K
Capitalization3.03B
Immatics
Price$5.81
Change+$0.06 (+1.04%)
Volume$10.13K
Capitalization706.21M
CRNX vs IMTX Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. IMTX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and IMTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (CRNX: $32.32 vs. IMTX: $5.81)
Brand notoriety: CRNX and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 56% vs. IMTX: 46%
Market capitalization -- CRNX: $3.03B vs. IMTX: $706.21M
CRNX [@Biotechnology] is valued at $3.03B. IMTX’s [@Biotechnology] market capitalization is $706.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRNX and IMTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 4 TA indicator(s) are bullish while IMTX’s TA Score has 6 bullish TA indicator(s).

  • CRNX’s TA Score: 4 bullish, 4 bearish.
  • IMTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а +5.90% price change this week, while IMTX (@Biotechnology) price change was +6.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

IMTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.03B) has a higher market cap than IMTX($706M). IMTX YTD gains are higher at: -19.128 vs. CRNX (-36.789). IMTX has higher annual earnings (EBITDA): -36.26M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. IMTX (491M). IMTX has less debt than CRNX: IMTX (16M) vs CRNX (50.8M). IMTX has higher revenues than CRNX: IMTX (116M) vs CRNX (760K).
CRNXIMTXCRNX / IMTX
Capitalization3.03B706M429%
EBITDA-373.49M-36.26M1,030%
Gain YTD-36.789-19.128192%
P/E RatioN/A27.61-
Revenue760K116M1%
Total Cash1.27B491M259%
Total Debt50.8M16M318%
FUNDAMENTALS RATINGS
CRNX vs IMTX: Fundamental Ratings
CRNX
IMTX
OUTLOOK RATING
1..100
868
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
63
Fair valued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
5187
PRICE GROWTH RATING
1..100
8355
P/E GROWTH RATING
1..100
10067
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMTX's Valuation (63) in the null industry is in the same range as CRNX (92) in the Pharmaceuticals Major industry. This means that IMTX’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (66) in the Pharmaceuticals Major industry is somewhat better than the same rating for IMTX (100) in the null industry. This means that CRNX’s stock grew somewhat faster than IMTX’s over the last 12 months.

CRNX's SMR Rating (51) in the Pharmaceuticals Major industry is somewhat better than the same rating for IMTX (87) in the null industry. This means that CRNX’s stock grew somewhat faster than IMTX’s over the last 12 months.

IMTX's Price Growth Rating (55) in the null industry is in the same range as CRNX (83) in the Pharmaceuticals Major industry. This means that IMTX’s stock grew similarly to CRNX’s over the last 12 months.

IMTX's P/E Growth Rating (67) in the null industry is somewhat better than the same rating for CRNX (100) in the Pharmaceuticals Major industry. This means that IMTX’s stock grew somewhat faster than CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXIMTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
79%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LICPX17.05N/A
N/A
Lord Abbett International Equity P
IFAFX26.16N/A
N/A
American Funds Income Fund of Amer F1
RNTTX47.91N/A
N/A
Russell Inv International Devd Mkts M
HFAEX15.26N/A
N/A
Hartford Schroders Intl Cntrrn Val C
THVRX29.64-0.04
-0.13%
Thornburg International Equity R4

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with CGON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-2.21%
CGON - IMTX
48%
Loosely correlated
-0.78%
KYMR - IMTX
47%
Loosely correlated
+1.56%
CRNX - IMTX
47%
Loosely correlated
+0.78%
IDYA - IMTX
46%
Loosely correlated
-2.50%
RGNX - IMTX
46%
Loosely correlated
-0.49%
More